Hospital Universitario de Salamanca -ko ikertzaileekin lankidetzan egindako argitalpenak (95)

2024

  1. Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study

    Journal of Clinical Medicine, Vol. 13, Núm. 2

2022

  1. Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy

    Pharmaceutics, Vol. 14, Núm. 1

2021

  1. Economic impact of the application of a precision medicine model (5SPM) on psychotic patients

    Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 1015-1025

2020

  1. Application of a pharmacogenetics-based precision medicine model (5SPM) to psychotic patients that presented poor response to neuroleptic therapy

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-16

  2. Consensus on recommendations for safe sexual activity during the covid-19 coronavirus pandemic

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-12

2019

  1. A Real-World Study on Antidepressant-Associated Sexual Dysfunction in 2144 Outpatients: The SALSEX I Study

    Archives of Sexual Behavior, Vol. 48, Núm. 3, pp. 923-933

  2. Frequency of sexual dysfunction in patients treated with desvenlafaxine: A prospective naturalistic study

    Journal of Clinical Medicine, Vol. 8, Núm. 5

  3. Hormonal contraceptives, female sexual dysfunction, and managing strategies: A review

    Journal of Clinical Medicine, Vol. 8, Núm. 6

  4. Online porn addiction: What we know and what we don’t—a systematic review

    Journal of Clinical Medicine, Vol. 8, Núm. 1

  5. Re: Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment

    Journal of Urology

  6. Sexual dysfunction and quality of life in chronic heroin-dependent individuals on methadone maintenance treatment

    Journal of Clinical Medicine, Vol. 8, Núm. 3

  7. Understanding the mechanism of antidepressant-related sexual dysfunction: Inhibition of tyrosine hydroxylase in dopaminergic neurons after treatment with paroxetine but not with agomelatine in male rats

    Journal of Clinical Medicine, Vol. 8, Núm. 2

2018

  1. Clinically significant personality traits in individuals at high risk of developing psychosis

    Psychiatry Research, Vol. 261, pp. 498-503

  2. Influence of personality traits on the severity of alcohol use disorders

    Journal of Clinical Medicine, Vol. 7, Núm. 6

  3. The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management

    World Psychiatry, Vol. 17, Núm. 1, pp. 3-11

2017

  1. Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics

    Frontiers in Neuroendocrinology, Vol. 45, pp. 25-34

  2. Radiocirugía en el Trastorno Obsesivocompulsivo, a propósito de un caso clínico

    Actas Espanolas de Psiquiatria

  3. Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values

    Schizophrenia Research, Vol. 189, pp. 69-74

2016

  1. Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos

    Revista de Psiquiatria y Salud Mental

  2. Pharmacogenetics to prevent maniac affective switching with treatment for bipolar disorder: CYP2D6

    Pharmacogenomics, Vol. 17, Núm. 12, pp. 1291-1293